Foundational Pathobiological and Novel Therapeutic Advances in Non-Cystic Fibrosis Bronchiectasis (NCFBE)
_{Emerging Investigational Evidence for Neutrophil-Directed Oral Therapies Based on DPP-1 Inhibition to Reduce Frequency of Exacerbations}